Patent details
EP2170388 Title: ANTI-CD20 ANTIBODY FORMULATIONS
Basic Information
- Publication number:
- EP2170388
- PCT Application Number:
- PCT/US/2008/069125
- Type:
- European Patent Granted for LU
- Legal Status:
- In force
- Application number:
- EP087813234
- PCT Publication Number:
- WO/2009/009407
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- ANTI-CD20 ANTIBODY FORMULATIONS
- French Title of Invention:
- FORMULATIONS D'ANTICORPS ANTI-CD20
- German Title of Invention:
- ANTI-CD20 ANTIKÖRPER-FORMULIERUNGEN
- SPC Number:
-
LUC00225
Dates
- Filing date:
- 03/07/2008
- Grant date:
- 12/10/2016
- EP Publication Date:
- 12/10/2016
- PCT Publication Date:
- 15/01/2009
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 07/04/2010
- EP B1 Publication Date:
- 12/10/2016
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 03/07/2028
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 03/07/2008
- Name:
- Novartis AG
- Address:
- Lichtstrasse 35, 4056 Basel, Switzerland (CH)
Inventor
1
- Name:
- LASHMAR Ulla, Tove
- Address:
- United Kingdom (GB)
2
- Name:
- KETKAR Amol, Sharad
- Address:
- United States (US)
3
- Name:
- BRISBANE Charlene, E.
- Address:
- United States (US)
Priority
- Priority Number:
- 948220 P
- Priority Date:
- 06/07/2007
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- C07K 16/00;
Annual Fees
- Annual Fee Due Date:
- 31/07/2025
- Annual Fee Number:
- 18
- Annual Fee Amount:
- 262 Euro
- Expected Payer:
- Last Annual Fee Payment Date:
- 26/06/2024
- Last Annual Fee Paid Number:
- 17
- Last Annual Fee Paid Amount:
- 246 Euro
- Payer:
- CPA GLOBAL THE IP PLATFORM
| Filing date | Document type | Number of pages |
|---|